- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.90 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x CYZ: CYCLOTHIAZIDE(Non-covalent)
- 6 x PLM: PALMITIC ACID(Non-covalent)
PLM.2: 4 residues within 4Å:- Chain A: W.548, Y.555, F.606
- Chain D: F.629
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:Y.555, A:F.606, D:F.629
PLM.6: 6 residues within 4Å:- Chain A: V.626
- Chain B: Y.819, G.823, G.824, L.827
- Ligands: PLM.8
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:Y.819, B:L.827, A:V.626
PLM.8: 6 residues within 4Å:- Chain B: V.536, Y.819
- Chain F: A.93, I.150, V.154
- Ligands: PLM.6
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain F- Hydrophobic interactions: B:Y.819, B:Y.819, F:I.150, F:V.154
PLM.11: 6 residues within 4Å:- Chain B: F.629
- Chain C: W.548, I.551, Y.555, F.606
- Ligands: OLC.12
4 PLIP interactions:3 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:I.551, C:Y.555, C:F.606, B:F.629
PLM.15: 6 residues within 4Å:- Chain C: V.626
- Chain D: V.536, Y.819, G.823, G.824
- Ligands: PLM.17
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:Y.819, C:V.626
PLM.17: 7 residues within 4Å:- Chain D: V.536, Y.819, I.822
- Chain H: A.93, I.150, V.154
- Ligands: PLM.15
4 PLIP interactions:2 interactions with chain H, 2 interactions with chain D- Hydrophobic interactions: H:I.150, H:V.154, D:Y.819, D:Y.819
- 4 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.3: 8 residues within 4Å:- Chain A: F.537, F.596, I.820
- Chain D: R.621, G.625, V.626, F.629
- Ligands: POV.19
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: A:F.596, A:I.820, A:I.820, D:V.626, D:F.629
OLC.7: 7 residues within 4Å:- Chain A: R.621, G.625, F.629
- Chain B: F.537, F.596, L.603, I.820
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:F.629, A:F.629, B:F.537, B:F.596, B:I.820
OLC.12: 9 residues within 4Å:- Chain B: G.625, V.626, F.629
- Chain C: F.537, F.596, L.603, I.820
- Ligands: PLM.11, POV.20
6 PLIP interactions:4 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:F.596, C:L.603, C:I.820, C:I.820, B:V.626, B:F.629
OLC.16: 7 residues within 4Å:- Chain C: R.621, G.625, F.629
- Chain D: F.537, F.596, L.603, I.820
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain D- Hydrophobic interactions: C:R.621, C:F.629, C:F.629, D:F.537, D:F.596, D:L.603, D:I.820
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
GLU.4: 10 residues within 4Å:- Chain A: Y.472, P.500, T.502, R.507, L.672, G.675, S.676, T.677, L.726, E.727
9 PLIP interactions:9 interactions with chain A,- Hydrophobic interactions: A:Y.472
- Hydrogen bonds: A:T.502, A:R.507, A:R.507, A:S.676, A:T.677, A:T.677, A:E.727, A:E.727
GLU.9: 10 residues within 4Å:- Chain B: Y.472, P.500, T.502, R.507, G.675, S.676, T.677, L.726, E.727, Y.754
10 PLIP interactions:10 interactions with chain B,- Hydrophobic interactions: B:Y.472, B:E.727
- Hydrogen bonds: B:P.500, B:T.502, B:R.507, B:R.507, B:S.676, B:T.677, B:T.677, B:E.727
GLU.13: 11 residues within 4Å:- Chain C: Y.472, P.500, T.502, R.507, L.672, G.675, S.676, T.677, L.726, E.727, Y.754
8 PLIP interactions:8 interactions with chain C,- Hydrophobic interactions: C:Y.472
- Hydrogen bonds: C:T.502, C:R.507, C:R.507, C:S.676, C:T.677, C:E.727, C:E.727
GLU.18: 9 residues within 4Å:- Chain D: Y.472, P.500, T.502, R.507, G.675, S.676, T.677, L.726, E.727
10 PLIP interactions:10 interactions with chain D,- Hydrophobic interactions: D:Y.472, D:E.727
- Hydrogen bonds: D:P.500, D:T.502, D:R.507, D:R.507, D:S.676, D:T.677, D:T.677, D:E.727
- 2 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.19: 14 residues within 4Å:- Chain A: V.536, F.537, Y.819, I.820, G.823, G.824, G.826, L.827
- Chain D: V.626
- Chain E: T.92, A.93, L.97, I.150
- Ligands: OLC.3
5 PLIP interactions:3 interactions with chain A, 1 interactions with chain D, 1 interactions with chain E- Hydrophobic interactions: A:F.537, A:Y.819, A:Y.819, D:V.626
- Hydrogen bonds: E:T.92
POV.20: 15 residues within 4Å:- Chain B: I.622, V.626
- Chain C: V.536, F.537, Y.819, I.820, G.823, G.824, G.826, L.827
- Chain G: T.92, A.93, L.97, I.150
- Ligands: OLC.12
8 PLIP interactions:4 interactions with chain C, 2 interactions with chain G, 2 interactions with chain B- Hydrophobic interactions: C:F.537, C:Y.819, C:Y.819, C:L.827, G:I.150, B:I.622, B:V.626
- Hydrogen bonds: G:T.92
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Structural mobility tunes signalling of the GluA1 AMPA glutamate receptor. Nature (2023)
- Release Date
- 2023-08-30
- Peptides
- Glutamate receptor 1 flip isoform: ABCD
Voltage-dependent calcium channel gamma-3 subunit: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.90 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x CYZ: CYCLOTHIAZIDE(Non-covalent)
- 6 x PLM: PALMITIC ACID(Non-covalent)
- 4 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
- 2 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Structural mobility tunes signalling of the GluA1 AMPA glutamate receptor. Nature (2023)
- Release Date
- 2023-08-30
- Peptides
- Glutamate receptor 1 flip isoform: ABCD
Voltage-dependent calcium channel gamma-3 subunit: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H - Membrane
-
We predict this structure to be a membrane protein.